Monitoring Movement Disorder Symptoms With a Mobile Medical App on Off-the-shelf Consumer Mobile Devices

Parkinson's & Movement Disorders Center of Maryland1 site in 1 country100 target enrollmentJanuary 19, 2019

ConditionsParkinson Disease

Overview

Phase: N/A
Intervention: Not specified
Conditions: Parkinson Disease
Sponsor: Parkinson's & Movement Disorders Center of Maryland
Enrollment: 100
Locations: 1
Primary Endpoint: NeuroRPM UPDRS predicted score vs. clinical raters' UPDRS
Status: Active, Not Recruiting
Last Updated: 3 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to evaluate whether New Touch Digital (NTD) NeuroRPM software installed on wearable devices can objectively measure and track symptoms in patients with Parkinson's disease.

Registry

clinicaltrials.gov

Start Date

January 19, 2019

End Date

August 1, 2023

Last Updated

3 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Parkinson's & Movement Disorders Center of Maryland

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Subject is 18 years of age or older
•Subject is able to provide informed written consent
•Subject has been clinically diagnosed with Parkinson's Disease
•Subject is mentally and physically capable of performing tasks on the mobile device and related physical activities herein described

Exclusion Criteria

•Inability to give informed consent
•Presence of additional neurological disease aside from the diseases being studied
•Inability to understand and follow the directions for the study

Outcomes

Primary Outcomes

NeuroRPM UPDRS predicted score vs. clinical raters' UPDRS

Time Frame: Comparison will be performed upon completion of the study, approximately in 1 year.

We will compare symptom severity as predicted by NeuroRPM to UPDRS scores from clinical raters. Statistical significance will be evaluated by intraclass correlation and kappa-statistic.